Molecular analysis of cancer using DNA and protein microarrays

Advances in Experimental Medicine and Biology

Volumn 532, Issue , 2003, Pages 51-58

  Madoz Gurpide, Juan ^b   Hanash, Sam M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; CONFERENCE PAPER; DNA MICROARRAY; DNA POLYMORPHISM; GENE EXPRESSION; GENOMICS; MUTATION; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS;

EID: 0141534371     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0081-0_6     Document Type: Conference Paper

References (44)

1. Petricoin, E.F., Zoon, K.C., Kohn, E.C., Barrett, J.C. & Liotta, L.A. Clinical proteomics: translating benchside promise into bedside reality. Nature Reviews Drug Discovery 1, 683-695 (2002).
2. Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
3. Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
4. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences, USA 98, 10869-10874 (2001).
5. Brenton, J.D., Aparicio, S.A. & Caldas, C. Molecular profiling of breast cancer: portraits but not physiognomy. Breast Cancer Research 3, 77-80 (2001).
6. Gruvberger, S. et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Research 61, 5979-5984 (2001).
7. Beer, D.G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinomas. Nature Medicine 8, 816-824 (2002).
8. Chen, G. et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clinical Cancer Research 8, 2290-2305 (2002).
9. Microarray standards at last. Nature 419, 323 (2002).
10. Ge, H. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Research 28, e3 (2000).
11. Rowe, C.A., Scruggs, S.B., Feldstein, M.J., Golden, J.P. & Ligler, F.S. An array immunosensor for simultaneous detection of clinical analytes. Analytical Biochemistry 71, 433-439 (1999).
12. Mendoza, L.G. et al. High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). Biotechniques 27, 778-780, 782-786, 788 (1999).
13. Silzel, J.W., Cercek, B., Dodson, C., Tsay, T. & Obremski, R.J. Mass-sensing, multianalyte microarray immunoassay with imaging detection. Clinical Chemistry 44, 2036-2043 (1998).
14. Arenkov, P. et al. Protein microchips: use for immunoassay and enzymatic reactions. Analytical Biochemistry 278, 123-131 (2000).
15. Haab, B.B., Dunham, M.J. & Brown, P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. GenomeBiology 2, Research0004.1-0004.13 (2001).
16. MacBeath, G. & Schreiber, S.L. Printing proteins as microarrays for high-throughput function determination. Science 289, 1760-1763 (2000).
17. Schweitzer, B. et al. Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proceedings of the National Academy of Sciences, USA 97, 10113-10119 (2000).
18. Bussow, K. et al. A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. Nucleic Acids Research 26, 5007-5008 (1998).
19. Lueking, A. et al. Protein microarrays for gene expression and antibody screening. Analytical Biochemistry 270, 103-111 (1999).
20. Zhu, H. et al. Analysis of yeast protein kinases using protein chips. Nature Genetics 26, 283-289 (2000).
21. DeWildt, R.M.T., Mundy, C.R., Gorick, B.D. & Tomlinson, I.M. Antibody arrays for high-throughtput screening of antibody-antigen interactions. Nature Biotechnology 18, 989-994 (2001).
22. Kononen, J. et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Medicine 4, 844-847 (1998).
23. Kallioniemi, O.P., Wagner, U., Kononen, J. & Sauter, G. Tissue microarray technology for high-throughput molecular profiling of cancer. Human Molecular Genetics 10, 657-662 (2001).
24. Paweletz, C.P. et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981-1989 (2001).
25. Pellois, J.P. et al. Individually addressable parallel peptide synthesis on microchips. Nature Biotechnology 20, 922-926 (2002).
26. Pawlak, M. et al. Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics 2, 383-393 (2002).
27. Knezevic, V. et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1, 1271-1278 (2001).
28. Robinson, W.H. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nature Medicine 8, 295-301 (2002).
29. Madoz-Gurpide, J., Wang, H., Misek, D.E., Brichory, F. & Hanash, S.M. Protein based microarrays: A tool for probing the proteome of cancer cells and tissues. Proteomics 1, 1279-1287 (2001).
30. Yamamoto, A. et al. Infrequent presence of anti-c-Myc antibodies and absence of c-Myce oncoprotein in sera from lung cancer patients. Oncology 56, 129-133 (1999).
31. Stockert, E. et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. Journal of Experimental Medicine 187, 1349-1354 (1998).
32. Gourevitch, M.M. et al. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. British Journal of Cancer 72, 934-938 (1995).
33. Gure, A.O. et al. Human lung cancer antigens recognized by autologous antibodies: Definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Research 58, 1034-1341 (1998).
34. Yamamoto, A., Shimizu, E., Ogura, T. & Sone, S. Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients. International Journal of Cancer 22, 283-289 (1996).
35. Soussi, T. The humoral response to the tumor-suppressor gene product p53 in human cancer: Implications for diagnosis and therapy. Immunology Today 17, 354-356 (1996).
36. Old, L.J. & Chen, Y.T. New paths in human cancer serology. Journal of Experimental Medicine 187, 1163-1167 (1998).
37. Le Naour, F. et al. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Molecular and Cellular Proteomics 1, 197-203 (2002).
38. Kodadek, T. Protein microarrays: Prospects and problems. Chemical Biology 8, 105-115 (2001).
39. Zhu, H. et al. Protein arrays and microarrays. Current Opinion in Chemical Biology 5, 40-45 (2001).
40. Senior, K. Fingerprinting disease with protein chip arrays. Molecular Medicine Today 5, 326-327 (1999).
41. Eggeling, F. et al. Tissue-specific microdissection coupled with ProteinChip array technologies. Applications in cancer research. Biotechniques 29, 1066-1070 (2000).
42. Madoz-Gúrpide, J. et al. Modulation of electroenzymatic NADPH oxidation through oriented immobilization of ferredoxin: NADP(+) reductase onto modified gold electrodes. Journal of the American Chemical Society 122, 9808-9817 (2000).
43. Delamarche, E. et al. Immobilization of antibodies on a photoactive self-assembled monolayer on gold. Langmuir, 12, 1997-2006 (1996).
44. Muller, W. et al. Attempts to mimic docking processes of the immune system: recognition-induced formation of protein multilayers. Science 262, 1706-1708 (1993).